Artivion (FRA:CYL) FFO


FRA:CYL Artivion Inc FRA:CYL
75 GF Score
Price €20.00
GF Value €24.03
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Artivion FFO?

FFO (Funds from operations) only applies to REITs.

FRA:CYL
75GF Score
Artivion Inc FRA:CYL
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Artivion (FRA:CYL) Overvalued in 2026?

Based on GuruFocus' analysis, Artivion stock appears to be undervalued. The current stock price of €20.00 is trading 16.8% below its estimated GF Value™ of €24.03. GuruFocus considers Artivion to be Modestly Undervalued.

Key valuation signals for FRA:CYL:

  • FFO:
  • GF Value™: €24.03 vs. price of €20.00 (16.8% below fair value)
  • GF Score™: 75/100 with 5 warning signs

No single metric tells the full story. See the FRA:CYL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Artivion Business Description

Other Exchanges AORT:USA
Address 1655 Roberts Boulevard North West, Kennesaw, GA, USA, 30144
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
75GF Score

Get the complete analysis for FRA:CYL

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€20.00
Price
€24.03
GF Value